Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Bonello

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|October 8, 2015
Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era beginsValeria Magarotto, Marco Salvini, Francesca Bonello, et al.
Expert Review of Anticancer Therapy|July 5, 2018
Determining treatment intensity in elderly patients with multiple myelomaMarco Salvini, Mattia D'Agostino, Francesca Bonello, et al.
Expert Review of Anticancer Therapy|April 19, 2025
An evaluation of epcoritamab as a treatment for relapsed or refractory follicular lymphomaFrancesca Bonello, Pio Manlio Mirko Frascione, Danilo Faraci, et al.
Expert Review of Hematology|May 16, 2017
How is patient care for multiple myeloma advancing?Sonja Genadieva Stavric, Francesca Bonello, Sara Bringhen, et al.
Expert Opinion on Biological Therapy|November 6, 2018
CD38 as an immunotherapeutic target in multiple myelomaFrancesca Bonello, Mattia D'Agostino, Maria Moscvin, et al.
Pharmaceuticals (Basel, Switzerland)|January 1, 2021
The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple MyelomaFrancesca Bonello, Mariella Grasso, Mattia D'Agostino, et al.
European Journal of Haematology|April 6, 2026
Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical ExperienceFrancesca Bonello, Andrea Aroldi, Alessia Castellino, et al.
Frontiers in Oncology|April 1, 2022
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple MyelomaFrancesca Bonello, Serena Rocchi, Gregorio Barilà, et al.
Current Research in Translational Medicine|March 11, 2023
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemiaGiorgia Battipaglia, Annamaria Vincenzi, Giulia Falconi, et al.
Haematologica|February 29, 2020
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studiesRoberto Mina, Francesca Bonello, Maria Teresa Petrucci, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|October 8, 2015
Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era beginsValeria Magarotto, Marco Salvini, Francesca Bonello, et al.
Expert Review of Anticancer Therapy|July 5, 2018
Determining treatment intensity in elderly patients with multiple myelomaMarco Salvini, Mattia D'Agostino, Francesca Bonello, et al.
Expert Review of Anticancer Therapy|April 19, 2025
An evaluation of epcoritamab as a treatment for relapsed or refractory follicular lymphomaFrancesca Bonello, Pio Manlio Mirko Frascione, Danilo Faraci, et al.
Expert Review of Hematology|May 16, 2017
How is patient care for multiple myeloma advancing?Sonja Genadieva Stavric, Francesca Bonello, Sara Bringhen, et al.
Expert Opinion on Biological Therapy|November 6, 2018
CD38 as an immunotherapeutic target in multiple myelomaFrancesca Bonello, Mattia D'Agostino, Maria Moscvin, et al.
Pharmaceuticals (Basel, Switzerland)|January 1, 2021
The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple MyelomaFrancesca Bonello, Mariella Grasso, Mattia D'Agostino, et al.
European Journal of Haematology|April 6, 2026
Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical ExperienceFrancesca Bonello, Andrea Aroldi, Alessia Castellino, et al.
Frontiers in Oncology|April 1, 2022
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple MyelomaFrancesca Bonello, Serena Rocchi, Gregorio Barilà, et al.
Current Research in Translational Medicine|March 11, 2023
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemiaGiorgia Battipaglia, Annamaria Vincenzi, Giulia Falconi, et al.
Haematologica|February 29, 2020
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studiesRoberto Mina, Francesca Bonello, Maria Teresa Petrucci, et al.
Pageof 3